CYP3A4*18 AND CYP3A5*3 GENE POLYMORPHISMS AND IMATINIB RESISTANCE IN MALAYSIAN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

被引：2
|
作者：
Ankathil, R. [1 ]
Zian, A. A. [1 ]
Nizam, Z. M. [1 ]
Azlan, H. [1 ]
Baba, A. A. [2 ]
机构：
[1] Univ Sains Malaysia, Ctr Human Genome, Kota Baharu, Kelantan, Malaysia
[2] Int Med Univ, Kuala Lumpur 57000, Malaysia
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/j.ejca.2014.03.267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P0223
引用
收藏
页码：E71 / E72
页数：2
相关论文
共 50 条
  • [1] CYP3A4*18 and CYP3A5*3 Polymorphisms in Modulating Susceptibility Risk in Malaysian Chronic Myeloid Leukaemia Patients
    Maddin, Najlaa
    Husin, Azlan
    Aziz, Baba Abdul
    Ankathil, Ravindran
    ARCHIVES OF OROFACIAL SCIENCE, 2020, 15 (01): : 23 - 33
  • [2] Association of CYP3A5*3, CYP3A4*18 & CYP2B6*6 polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients
    Asadov, Chingiz
    Karimova, Nigar
    Hasanova, Aypara
    Bayramov, Bayram
    Shirinova, Aytan
    Alimirzoyeva, Zohra
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2023, 158 (02) : 151 - 160
  • [3] Impact of CYP3A4*18 and CYP3A5*3 Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia
    Maddin, Najlaa
    Husin, Azlan
    Gan, Siew Hua
    Aziz, Baba Abdul
    Ankathil, Ravindran
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 303 - 314
  • [4] Impact of CYP3A4*18 and CYP3A5*3 Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia
    Najlaa Maddin
    Azlan Husin
    Siew Hua Gan
    Baba Abdul Aziz
    Ravindran Ankathil
    Oncology and Therapy, 2016, 4 (2) : 303 - 314
  • [5] CYP3A5*3, CYP3A4*18 and CYP2B6 gene polymorphisms in chronic myeloid leukemia patients in Azerbaijan
    Asadov, C.
    Karimova, N.
    Hasanova, A.
    Shirinova, A.
    LEUKEMIA RESEARCH, 2019, 85 : S30 - S30
  • [6] Analysis of CYP3A5*3 and CYP3A5*6 Gene Polymorphisms in Indian Chronic Myeloid Leukemia Patients
    Sailaja, K.
    Surekha, D.
    Rao, D. Nageswara
    Rao, D. Raghunadha
    Vishnupriya, S.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (03) : 781 - 784
  • [7] CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population
    Hu, YF
    He, J
    Chen, GL
    Wang, D
    Liu, ZQ
    Zhang, C
    Duan, LF
    Zhou, HH
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 187 - 192
  • [8] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06): : 479 - 484
  • [9] Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms
    Riffi, Rachda
    Boughrara, Wefa
    Chentouf, Amina
    Ilias, Wassila
    Brahim, Narimene Malika Taieb
    Berrebbah, Amel Alioua
    Belhoucine, Fatma
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (12) : 1463 - 1473
  • [10] CYP3A4 and CYP3A5 genotyping by pyrosequencing
    Garsa, AA
    McLeod, HL
    Marsh, S
    BMC MEDICAL GENETICS, 2005, 6
12345